Sugi Predict

Sugi Predict / Compounds / SCHEMBL450161

SCHEMBL450161

SCHEMBL450161

CCCCCCCCCCCCCC/C=C/[O]

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FAAH O00519 2/20 0.61
▸ TRPV1 Q8NER1 1/20 0.61
▸ FABP3 P05413 5/20 0.56
▸ TSHR P16473 1/20 0.55
▸ TERT O14746 2/20 0.52
▸ GMNN O75496 1/20 0.52
▸ USP2 O75604 1/20 0.52
▸ LMNA P02545 1/20 0.52
▸ CYP1A2 P05177 1/20 0.52
▸ POLB P06746 1/20 0.52
▸ MAPT P10636 1/20 0.52
▸ CYP2C9 P11712 1/20 0.52
▸ ALOX15 P16050 1/20 0.52
▸ APEX1 P27695 1/20 0.52
▸ CYP2C19 P33261 1/20 0.52
▸ RECQL P46063 1/20 0.52
▸ BLM P54132 1/20 0.52
▸ NPSR1 Q6W5P4 1/20 0.52
▸ HSD17B10 Q99714 1/20 0.52
▸ DUSP3 P51452 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL449542 1.00 FAAH (0.61) FAAHTRPV1FABP3TSHRTERT
SCHEMBL129255 1.00 FAAH (0.61) FAAHTRPV1FABP3TSHRTERT
SCHEMBL131677 1.00 FAAH (0.61) FAAHTRPV1FABP3TSHRTERT
SCHEMBL451503 1.00 FAAH (0.61) FAAHTRPV1FABP3TSHRTERT
SCHEMBL131304 1.00 FAAH (0.61) FAAHTRPV1FABP3TSHRTERT
SCHEMBL130541 1.00 FAAH (0.61) FAAHTRPV1FABP3TSHRTERT
SCHEMBL449541 1.00 FAAH (0.61) FAAHTRPV1FABP3TSHRTERT
SCHEMBL450162 1.00 FAAH (0.61) FAAHTRPV1FABP3TSHRTERT
SCHEMBL449598 1.00 FAAH (0.61) FAAHTRPV1FABP3TSHRTERT
SCHEMBL130013 1.00 FAAH (0.61) FAAHTRPV1FABP3TSHRTERT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11981619-B2 Alkoxylated esteramines and salts thereof BASF SE (DE) 2024-05-14 — — US disclosed
EP-3649224-B1 CLEANING COMPOSITIONS COMPRISING ALKOXYLATED ESTERAMINES PROCTER & GAMBLE (US) 2023-12-27 — — EP disclosed
CN-117024291-A Alkoxylated ester amines and salts thereof 巴斯夫欧洲公司 2023-11-10 — — CN disclosed
CN-116745272-A Compound, cell vesicle staining agent, and method for fluorescent staining of cell vesicles 国立大学法人东海国立大学机构 2023-09-12 — — CN disclosed
US-11673854-B2 Alkoxylated esteramines and salts thereof BASF SE 2023-06-13 — — US disclosed
CN-110997891-B Cleaning compositions comprising alkoxylated esteramines 宝洁公司 2021-05-07 — — CN disclosed
US-20200188257-A1 ALKOXYLATED ESTERAMINES AND SALTS THEREOF BASF SE (DE) 2020-06-18 — — US disclosed
EP-3649224-A1 CLEANING COMPOSITIONS COMPRISING ALKOXYLATED ESTERAMINES The Procter and Gamble Company (US) 2020-05-13 — — EP disclosed
EP-3649174-A1 ALKOXYLATED ESTERAMINES AND SALTS THEREOF BASF SE (DE) 2020-05-13 — — EP disclosed
US-20200140374-A1 ALKOXYLATED ESTERAMINES AND SALTS THEREOF BASF SE (DE) 2020-05-07 — — US disclosed
EP-0627406-A1 2-AMINO-1,3-PROPANEDIOL COMPOUND AND IMMUNOSUPPRESSANT YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1994-12-07 — — EP disclosed
EP-0619345-A1 Phthalocyanine compound and optical recording medium containing it MITSUI TOATSU CHEMICALS, Inc. (JP) 1994-10-12 — — EP disclosed
US-5211877-A Crosslinked resins CONSORTIUM FUR ELEKTROCHEMISCHE INDUSTRIE GMBH (DE) 1993-05-18 — — US disclosed
US-5116858-A Learning enhancement MITSUBISHI KASEI CORPORATION (JP) 1992-05-26 — — US disclosed
EP-0396973-A1 4-Imidazoline derivatives and their use in preparing pharmaceutical compositions MITSUBISHI KASEI CORPORATION (JP) 1990-11-14 — — EP disclosed
EP-0088046-B1 LIPIDS IN THE AQUEOUS PHASE CIBA-GEIGY AG (CH) 1987-12-09 — — EP disclosed
US-4619794-A Spontaneous preparation of small unilamellar liposomes CIBA-GEIGY CORPORATION (US) 1986-10-28 — — US disclosed
EP-0071892-B1 PHOSPHOLIPID DERIVATIVES, PROCESS FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION OF THE SAME FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1985-10-23 — — EP disclosed
EP-0088046-A2 Lipids in the aqueous phase CIBA-GEIGY AG (CH) 1983-09-07 — — EP disclosed
EP-0071892-A2 Phospholipid derivatives, process for preparation thereof and pharmaceutical composition of the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1983-02-16 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11981619-B2 Alkoxylated esteramines and salts thereof ALKBH3, ALKBH1, ABHD6 FAAH 59/4885TRPV1 2907/4885FABP3 2366/4885
US-20200140374-A1 ALKOXYLATED ESTERAMINES AND SALTS THEREOF ALKBH3, ALKBH1, ABHD6 FAAH 59/4885TRPV1 2907/4885FABP3 2366/4885
US-20200188257-A1 ALKOXYLATED ESTERAMINES AND SALTS THEREOF ALKBH3, ALKBH1, ABHD6 FAAH 59/4885TRPV1 2907/4885FABP3 2366/4885
US-11673854-B2 Alkoxylated esteramines and salts thereof ALKBH3, ALKBH1, ABHD6 FAAH 59/4885TRPV1 2907/4885FABP3 2366/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.